Pharmacometric Analysis

Pharmacometric analysis allows you to learn from your data, quantify it, then apply it to next step!


- Population PK/PD analysis
- Nonclinical PK/PD modeling & simulation
- First-in-Human (FIH) dose estimation based on nonclinical PK/PD modeling
- Human PK/PD evaluation via early clinical trial data
- Non-Compartmental Analysis (NCA) on early clinical trial data
- Drug development consultation on clinical study design
- Pharmacometric consultation: Liaison services with bioanalytical facilities and  
sponsors to ensure PK data integrity and to provide data  interpretation
- Scientific report writing

- DDI Prediction

Provide Solutions to Questions 


Our projects are often initiated via in-person discussion followed by confidentiality documents. Following the delivery of quotation outlining estimated timeline and project cost, a contract is made upon mutual agreement. Data set is received via exchange of internet electronic files. Preliminary analysis is done and regular in-house meetings with sponsors follow on an as-needed basis. International consultation is also available via telecommunication or email.


Non-Clinical to Clinical Trial Translation

Next Step Clinical Trial Translation